Mayo Clinic Doctor Says Mark Cuban’s Cost Plus Drugs is Bringing “Access” to U.S. Healthcare

 

Mark Cuban’s Cost Plus Drugs is making waves in the pharmacy market, gaining more than 1.2 million customers and selling over 1000 generic low-cost drugs at a fraction of the prescription price that Big Pharma puts on the marketplace. The big question now is whether the supply chain can fundamentally shift toward Cuban’s low-cost model as brand-name drugs resist the shift. Assistant Professor of Epidemiology for the Mayo Clinic College of Medicine at Mayo Clinic, Dr. Jose Medina-Inojosa, breaks down the ripple effects from the Cost Plus Drugs approach to drug product logistics.

Dr. Medina-Inojosa’s Thoughts

“Just to give you a little of context, as we all know, we are probably working in the best healthcare system of the world, but one of the major challenges that we have is access, and specifically prescription access is becoming a major problem in the United States. About 18 million people, about 7% of the whole United States, have a lot of trouble accessing medications and this company is probably gonna help some of the problems. They’re based in Dallas, they’re expanding access, they’re negotiating new deals with drug companies, getting access to generic medications that are about 85% cheaper. Talking about, to give you some example for some leukemia medications, it could take a drug from $2,500 to $14 at Mark Cuban’s Cost Plus Drugs, which is extremely exciting.

They’re also working with manufacturing their ordinary prescription medications in Dallas, and I think down the line they’re promising to continue to expand their deals and their reach over the next six or 12 months. So it’s not the major solution to fix all the problems, but I think it’s a really good step in the right direction. And I’m looking forward to see how it will help shape the face of healthcare and how it will help deliver access.”

Follow us on social media for the latest updates in B2B!

Image

Latest

sterile compounding
Sterile Compounding and Contamination Control with Abby Roth
March 11, 2025

In this episode of Exceeding Your Benchmark, host Michelle Dawn Mooney speaks with Abby Roth, founder of Pure Microbiology, about sterile compounding and contamination control. Abby shares her expertise in microbiology, sterile environments, and best practices in pharmaceutical compounding. The conversation begins with a distinction between traditional drug manufacturing and sterile compounding, highlighting the…

Read More
hearing test
Convenient Online Hearing Test from HearUSA Enhances Your Hearing Health Journey
March 11, 2025

Struggling to hear conversations could be more prevalent than you think. As a leader in hearing care, HearUSA offers an easy solution that you can manage from the comfort of your home: the HearUSA Online Hearing Test. Experience the Simplicity This quick, free, and convenient online test is designed to examine your hearing in…

Read More
Lessons from Gen Z: Why Marketers Need to Adapt to Current Digital Trends
Lessons from Gen Z: Why Marketers Need to Adapt to Current Digital Trends
March 7, 2025

On this episode of UGC for B2B, hosts Hunter Lopatin and Jamison Wheeler take over for a special Gen Z edition, breaking down why big brands struggle to embrace user-generated content (UGC) and how the next generation is reshaping the marketing landscape. As a former NCAA athlete and current B2B marketing professional, Jamison shares firsthand…

Read More
Stephanie Simon
Through the Storm with USMC Captain, Professional Boxer, and TrailBlazer, Stephanie Simon
March 7, 2025

Captain Stephanie Simon (USMC) is currently a professional boxer (2-0), a boxing instructor, and a Marine Corps reservist. She is the 2024 Olympic Trials Boxing Champion, 4x Elite National Boxing Champion, 3x National Collegiate Boxing Champion, and United States Marine Corps Boxing Hall of Famer. Stephanie Simon is originally from Atlanta, GA, grew up…

Read More